Email address
[email protected]Contact number
+1 617 951 7000Provided by Ropes & Gray LLP
A Destination M&A Practice
Recognized as leaders in the field, our M&A attorneys possess both extensive transactional experience and deep industry knowledge. We hold a strong track record of advising strategic investors on a wide variety of corporate transactions, creating and implementing innovative deal structures driven by industry trends and evolving market terms.
Our transaction teams include attorneys with various specialties, including tax, intellectual property, finance, antitrust, employee benefits, environmental, litigation, and government enforcement, which allow us to present an integrated service offering to resolve matters that span the full spectrum of transaction-related issues.
A Client-Centric Focus
Clients value a firm with the global resources—and steadfast commitment to cultivating relationships—to achieve their business goals. Ropes & Gray’s M&A attorneys navigate clients through some of the largest, most complex and demanding transactions around the world. We are consistently recognized for our excellence in client service and responsiveness, delivering the quick turnaround needed to keep pace with business demands.
To learn more about our practice, please visit: https://www.ropesgray.com/practices/mergers--acquisitions.aspx
Provided by Chambers
Ropes & Gray advised Novo Nordisk in connection with its $5.2 billion acquisition of Akero Therapeutics.
Provided by Chambers
They are very service- and client-oriented. They provide practical advice and help us make good decisions based on a risk assessment.
They are very service- and client-oriented. They provide practical advice and help us make good decisions based on a risk assessment.
Provided by Chambers
Marko Zatylny is experienced in advising industry players in high-value M&A. He works for a range of clients, most notably those in the life sciences, technology and energy sectors.
He's a real strategic advisor who will help make pragmatic and practical decisions. He makes the complicated things really simple, and is able to really cut through noise.
Emily Oldshue is a talented up-and-comer with expertise in high-profile M&A transactions. She frequently represents both public and private companies in areas including pharmaceuticals and biotech.